Ventilator-associated Pneumonia in Adults: a Narrative Review

Overview

Journal Intensive Care Med

Specialty Critical Care

Date 2020 Mar 12

PMID 32157357

Citations 263

Authors

Laurent Papazian

Michael Klompas

Charles-Edouard Luyt

Affiliations

Soon will be listed here.

Abstract

Ventilator-associated pneumonia (VAP) is one of the most frequent ICU-acquired infections. Reported incidences vary widely from 5 to 40% depending on the setting and diagnostic criteria. VAP is associated with prolonged duration of mechanical ventilation and ICU stay. The estimated attributable mortality of VAP is around 10%, with higher mortality rates in surgical ICU patients and in patients with mid-range severity scores at admission. Microbiological confirmation of infection is strongly encouraged. Which sampling method to use is still a matter of controversy. Emerging microbiological tools will likely modify our routine approach to diagnosing and treating VAP in the next future. Prevention of VAP is based on minimizing the exposure to mechanical ventilation and encouraging early liberation. Bundles that combine multiple prevention strategies may improve outcomes, but large randomized trials are needed to confirm this. Treatment should be limited to 7 days in the vast majority of the cases. Patients should be reassessed daily to confirm ongoing suspicion of disease, antibiotics should be narrowed as soon as antibiotic susceptibility results are available, and clinicians should consider stopping antibiotics if cultures are negative.

Citing Articles

The Development of a 10-Item Ventilator-Associated Pneumonia Care Bundle in the General Intensive Care Unit of a Tertiary Hospital in Vietnam: Lessons Learned.

Giang B, Matsubara C, Okamoto T, Hoan H, Yonehiro Y, Nguyen D Healthcare (Basel). 2025; 13(5).

PMID: 40077006 PMC: 11899602. DOI: 10.3390/healthcare13050443.

Bacterial Colonization of Silver-Additive Ventilator Circuit in Patients Receiving Mechanical Ventilation: A Randomized Controlled Trial.

Chao K, Liu W, Chen C, Su C, Yang S, Huang Y Clin Respir J. 2025; 19(3):e70058.

PMID: 40052538 PMC: 11886615. DOI: 10.1111/crj.70058.

Predictive model for postoperative pneumonia in patients with esophageal cancer after esophagectomy.

Chen J, Xiang Q, Zheng X, Jiang X Front Oncol. 2025; 15:1529308.

PMID: 40027123 PMC: 11868259. DOI: 10.3389/fonc.2025.1529308.

Early Predictive Value of Infectious Markers for Ventilator-associated Pneumonia after Stanford Type A Aortic Dissection Surgery.

Deng H, Wu X, Peng B Rev Cardiovasc Med. 2025; 26(2):26002.

PMID: 40026526 PMC: 11868900. DOI: 10.31083/RCM26002.

Application of double-sleeve endotracheal tube in infection control for icu patients: a randomized controlled trial.

Sheng H, Wang L, Fei Y, Zhu Z, Wang P Head Face Med. 2025; 21(1):12.

PMID: 40011996 PMC: 11863518. DOI: 10.1186/s13005-025-00488-8.

References

Rodriguez-Bano J, Gutierrez-Gutierrez B, Kahlmeter G . Antibiotics for Ceftriaxone-Resistant Gram-Negative Bacterial Bloodstream Infections. JAMA. 2019; 321(6):612-613. DOI: 10.1001/jama.2018.19345. View

Klompas M . Does this patient have ventilator-associated pneumonia?. JAMA. 2007; 297(14):1583-93. DOI: 10.1001/jama.297.14.1583. View

Esperatti M, Ferrer M, Theessen A, Liapikou A, Valencia M, Saucedo L . Nosocomial pneumonia in the intensive care unit acquired by mechanically ventilated versus nonventilated patients. Am J Respir Crit Care Med. 2010; 182(12):1533-9. DOI: 10.1164/rccm.201001-0094OC. View

Khan R, Al-Dorzi H, Tamim H, Rishu A, Balkhy H, El-Saed A . The impact of onset time on the isolated pathogens and outcomes in ventilator associated pneumonia. J Infect Public Health. 2015; 9(2):161-71. DOI: 10.1016/j.jiph.2015.09.002. View

Luyt C, Faure M, Bonnet I, Besset S, Huang F, Junot H . Use of non-carbapenem antibiotics to treat severe extended-spectrum β-lactamase-producing Enterobacteriaceae infections in intensive care unit patients. Int J Antimicrob Agents. 2019; 53(5):547-552. DOI: 10.1016/j.ijantimicag.2019.02.001. View

Deschepper M, Waegeman W, Eeckloo K, Vogelaers D, Blot S . Effects of chlorhexidine gluconate oral care on hospital mortality: a hospital-wide, observational cohort study. Intensive Care Med. 2018; 44(7):1017-1026. PMC: 6061438. DOI: 10.1007/s00134-018-5171-3. View

Li Y, Liu C, Xiao W, Song T, Wang S . Incidence, Risk Factors, and Outcomes of Ventilator-Associated Pneumonia in Traumatic Brain Injury: A Meta-analysis. Neurocrit Care. 2019; 32(1):272-285. PMC: 7223912. DOI: 10.1007/s12028-019-00773-w. View

Fagon J, Chastre J, HANCE A, Montravers P, Novara A, Gibert C . Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med. 1993; 94(3):281-8. DOI: 10.1016/0002-9343(93)90060-3. View

Letvin A, Kremer P, Silver P, Samih N, Reed-Watts P, Kollef M . Frequent Versus Infrequent Monitoring of Endotracheal Tube Cuff Pressures. Respir Care. 2018; 63(5):495-501. DOI: 10.4187/respcare.05926. View

10.

Kalil A, Metersky M, Klompas M, Muscedere J, Sweeney D, Palmer L . Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016; 63(5):e61-e111. PMC: 4981759. DOI: 10.1093/cid/ciw353. View

11.

Blot S, Taccone F, Van den Abeele A, Bulpa P, Meersseman W, Brusselaers N . A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients. Am J Respir Crit Care Med. 2012; 186(1):56-64. DOI: 10.1164/rccm.201111-1978OC. View

12.

Combes A, Figliolini C, Trouillet J, Kassis N, Wolff M, Gibert C . Incidence and outcome of polymicrobial ventilator-associated pneumonia. Chest. 2002; 121(5):1618-23. DOI: 10.1378/chest.121.5.1618. View

13.

Wunderink R, Woldenberg L, Zeiss J, Day C, Ciemins J, Lacher D . The radiologic diagnosis of autopsy-proven ventilator-associated pneumonia. Chest. 1992; 101(2):458-63. DOI: 10.1378/chest.101.2.458. View

14.

Ong D, Bonten M, Spitoni C, Verduyn Lunel F, Frencken J, Horn J . Epidemiology of Multiple Herpes Viremia in Previously Immunocompetent Patients With Septic Shock. Clin Infect Dis. 2017; 64(9):1204-1210. DOI: 10.1093/cid/cix120. View

15.

Limaye A, Kirby K, Rubenfeld G, Leisenring W, Bulger E, Neff M . Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA. 2008; 300(4):413-22. PMC: 2774501. DOI: 10.1001/jama.300.4.413. View

16.

Santacruz C, Pereira A, Celis E, Vincent J . Which Multicenter Randomized Controlled Trials in Critical Care Medicine Have Shown Reduced Mortality? A Systematic Review. Crit Care Med. 2019; 47(12):1680-1691. DOI: 10.1097/CCM.0000000000004000. View

17.

Hong H, Hong S, Ko G, Huh J, Sung H, Do K . Viral infection is not uncommon in adult patients with severe hospital-acquired pneumonia. PLoS One. 2014; 9(4):e95865. PMC: 3994115. DOI: 10.1371/journal.pone.0095865. View

18.

Schuetz P, Wirz Y, Sager R, Christ-Crain M, Stolz D, Tamm M . Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. Lancet Infect Dis. 2017; 18(1):95-107. DOI: 10.1016/S1473-3099(17)30592-3. View

19.

Gibot S, Cravoisy A, Levy B, Bene M, Faure G, Bollaert P . Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med. 2004; 350(5):451-8. DOI: 10.1056/NEJMoa031544. View

20.

Melsen W, Rovers M, Groenwold R, Bergmans D, Camus C, Bauer T . Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies. Lancet Infect Dis. 2013; 13(8):665-71. DOI: 10.1016/S1473-3099(13)70081-1. View